X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4462) 4462
Book Chapter (29) 29
Publication (12) 12
Newsletter (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3470) 3470
asthma (2169) 2169
index medicus (2043) 2043
inhaled corticosteroids (1983) 1983
respiratory system (1873) 1873
male (1839) 1839
female (1807) 1807
asthma - drug therapy (1576) 1576
administration, inhalation (1573) 1573
adult (1148) 1148
middle aged (1084) 1084
bronchodilator agents - administration & dosage (870) 870
bronchodilator agents - therapeutic use (859) 859
corticosteroids (800) 800
treatment outcome (800) 800
aged (773) 773
allergy (736) 736
child (730) 730
obstructive pulmonary-disease (705) 705
pulmonary disease, chronic obstructive - drug therapy (681) 681
asthma - physiopathology (680) 680
chronic obstructive pulmonary disease (662) 662
adolescent (654) 654
drug therapy (642) 642
pharmacology & pharmacy (612) 612
immunology (605) 605
double-blind method (599) 599
copd (595) 595
children (592) 592
salmeterol (585) 585
budesonide (567) 567
fluticasone (532) 532
anti-asthmatic agents - therapeutic use (504) 504
double-blind (492) 492
fluticasone propionate (485) 485
adrenal cortex hormones - administration & dosage (466) 466
drug therapy, combination (463) 463
care and treatment (462) 462
lung diseases, obstructive (445) 445
lung-function (443) 443
adrenal cortex hormones - therapeutic use (437) 437
medicine, general & internal (435) 435
therapy (434) 434
pediatrics (428) 428
exacerbations (419) 419
inflammation (415) 415
child, preschool (383) 383
risk factors (377) 377
efficacy (374) 374
forced expiratory volume (359) 359
research (355) 355
asthma - diagnosis (352) 352
severity of illness index (341) 341
respiratory tract diseases (335) 335
mortality (333) 333
pulmonary disease, chronic obstructive - physiopathology (326) 326
studies (322) 322
airway inflammation (316) 316
critical care medicine (315) 315
inhaled corticosteroid (315) 315
animals (312) 312
anti-asthmatic agents - administration & dosage (312) 312
nebulizers and vaporizers (311) 311
safety (307) 307
albuterol - analogs & derivatives (305) 305
bronchodilator agents - adverse effects (304) 304
dose-response relationship, drug (300) 300
forced expiratory volume - drug effects (299) 299
health aspects (298) 298
management (298) 298
formoterol (297) 297
analysis (293) 293
respiratory function tests (292) 292
adrenergic beta-agonists - therapeutic use (291) 291
albuterol - administration & dosage (287) 287
salmeterol xinafoate (287) 287
dosage and administration (282) 282
cardiac & cardiovascular systems (278) 278
abridged index medicus (275) 275
risk (274) 274
quality of life (272) 272
albuterol - therapeutic use (271) 271
time factors (267) 267
androstadienes - administration & dosage (265) 265
respiratory agents (262) 262
tiotropium (262) 262
bronchodilators (254) 254
steroids (254) 254
childhood asthma (251) 251
pulmonary/respiratory (246) 246
drug administration schedule (245) 245
salbutamol (245) 245
persistent asthma (244) 244
pulmonary disease, chronic obstructive - diagnosis (243) 243
budesonide - administration & dosage (241) 241
patients (240) 240
diagnosis (238) 238
clinical trials (235) 235
adults (234) 234
lung - physiopathology (234) 234
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4397) 4397
French (57) 57
Spanish (26) 26
German (19) 19
Japanese (17) 17
Italian (3) 3
Russian (3) 3
Korean (2) 2
Portuguese (2) 2
Chinese (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Thorax, ISSN 0040-6376, 12/2011, Volume 66, Issue 12, pp. 1029 - 1035
.... Currently approved bronchodilators such as long-acting β2 adrenoceptor agonists are the mainstay treatments but often fail to relieve symptoms of chronic obstructive... 
GLOBAL STRATEGY | PROSTANOID RECEPTORS | SMOOTH-MUSCLE | SUBTYPES | RESPIRATORY SYSTEM | INHALED PROSTAGLANDIN-E2 | PREVENTION | ASTHMA | RELAXATION | PGE | AGONIST | Species Specificity | Humans | Macaca fascicularis | Trachea - drug effects | Pulmonary Disease, Chronic Obstructive - physiopathology | Xanthones - pharmacology | Alprostadil - analogs & derivatives | Prostanoic Acids - pharmacology | Phenylbutyrates - pharmacology | Trachea - physiology | Dinoprostone - pharmacology | Hydrazines - pharmacology | Guinea Pigs | Asthma - physiopathology | Mice, Inbred C57BL | Alprostadil - pharmacology | Rats | Bronchodilator Agents - pharmacology | Methyl Ethers - pharmacology | Asthma - drug therapy | Rats, Sprague-Dawley | Naphthalenes - pharmacology | Receptors, Prostaglandin E - physiology | Regression Analysis | Animals | Receptors, Prostaglandin E - agonists | Dinoprostone - analogs & derivatives | Mice | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Prostaglandins E | Physiological aspects | Drug targeting | Research | Drug therapy | Identification and classification | Bronchodilator agents | Drug receptors | Index Medicus | Relaxation | Airway Biology | prostanoids | asthma pharmacology | airway smooth muscle | 1506 | respiratory muscles | prostanoid receptors
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 12/2017, Volume 2017, Issue 12, p. CD012102
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1176-9106, 10/2016, Volume 11, Issue 1, pp. 2191 - 2201
PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness regarding lung function and health... 
sex difference | treatment duration | Netherlands | Health economics | survival rate | tiotropium bromide | disease duration | quality adjusted life year | disease severity | human | olodaterol plus tiotropium bromide | disease exacerbation | drug cost | Budget impact | health care cost | medication compliance | treatment outcome | article | age distribution | forced expiratory volume | Cost–utility | chronic obstructive lung disease | cost effectiveness analysis | Cost-effectiveness | COPD | cost-effectiveness | UTILITY ANALYSIS | DAILY MAINTENANCE BRONCHODILATOR | SAFETY | INHALED CORTICOSTEROIDS | RISK | budget impact | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | PLUS OLODATEROL | EXACERBATIONS | ECONOMIC-IMPACT | RESPIMAT(R) | cost-utility | health economics | Bronchodilator Agents - therapeutic use | Drug Costs | Pulmonary Disease, Chronic Obstructive - mortality | Markov Chains | Cholinergic Antagonists - economics | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Models, Economic | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Tiotropium Bromide - therapeutic use | Budgets | Pulmonary Disease, Chronic Obstructive - economics | Cholinergic Antagonists - therapeutic use | Quality-Adjusted Life Years | Severity of Illness Index | Bronchodilator Agents - economics | Treatment Outcome | Lung - physiopathology | Disease Progression | Benzoxazines - therapeutic use | Tiotropium Bromide - economics | Medication Adherence | Adrenergic beta-2 Receptor Agonists - economics | Cost-Benefit Analysis | Lung - drug effects | Aged | Benzoxazines - economics | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Markov processes | Economic aspects | Lung diseases, Obstructive | Analysis
Journal Article
Chest, ISSN 0012-3692, 08/2018, Volume 154, Issue 2, pp. 242 - 248
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2007, Volume 120, Issue 5, pp. 1065 - 1072
Journal Article